Targeting the production of oncogenic MicroRNAs with multimodal synthetic small molecules

ACS Chemical Biology

Volumn 9, Issue 3, 2014, Pages 711-721

  Vo, Duc Duy ^a   Staedel, Cathy ^b   Zehnacker, Laura ^a   Benhida, Rachid ^a   Darfeuille, Fabien ^b   Duca, Maria ^a  

^a UNIVERSITÉ DE NICE SOPHIA ANTIPOLIS   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BOC NEOMYCIN A; BOC NEOMYCIN BIG; BOC NEOMYCIN C; BOC NEOMYCIN D3; BOC NEOMYCIN D4; BOC NEOMYCIN G; BOC NEOMYCIN HB; BOC NEOMYCIN HB AR; BOC NEOMYCIN S; BOC NEOMYCIN U; MICRORNA; MICRORNA 372; MICRORNA 373; NEAMINE; NEOMYCIN; NEOMYCIN BIG; NEOMYCIN CYTOSIN; NEOMYCIN D4; NEOMYCIN G; NEOMYCIN HB; NEOMYCIN HBBAR; NEOMYCIN S; NEOMYCIN U; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; LIGAND; MIRN372 MICRORNA, HUMAN; MIRN373 MICRORNA, HUMAN; MOLECULAR LIBRARY;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BIOSYNTHESIS; CANCER CELL; CONJUGATION; CYCLOADDITION; GENE TARGETING; ONCOGENE; PRIORITY JOURNAL; RNA BINDING; RNA STRUCTURE; STOMACH CANCER; ANTAGONISTS AND INHIBITORS; CELL PROLIFERATION; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; DRUG EFFECTS; GENETICS; HUMAN; MOLECULAR LIBRARY; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PHARMACOLOGY; STOMACH NEOPLASMS; SYNTHESIS; THERAPEUTIC USE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DRUG DESIGN; HUMANS; LIGANDS; MICRORNAS; MOLECULAR STRUCTURE; MOLECULAR TARGETED THERAPY; SMALL MOLECULE LIBRARIES; STOMACH NEOPLASMS;

EID: 84896969123     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb400668h     Document Type: Article

References (48)

1. Ambros, V. (2008) The evolution of our thinking about microRNAs Nat. Med. 14, 1036-1040
2. Vasudevan, S., Tong, Y., and Steitz, J. A. (2007) Switching from repression to activation: microRNAs can up-regulate translation Science 318, 1931-1934
3. Kim, V. N., Han, J., and Siomi, M. C. (2009) Biogenesis of small RNAs in animals Nat. Rev. Mol. Cell Biol. 10, 126-139
4. Iorio, M. V. and Croce, C. M. (2012) Causes and consequences of microRNA dysregulation Cancer J. 18, 215-222
5. Olson, P., Lu, J., Zhang, H., Shai, A., Chun, M. G., Wang, Y., Libutti, S. K., Nakakura, E. K., Golub, T. R., and Hanahan, D. (2009) MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer Genes Dev. 23, 2152-2165
6. Calin, G. A. and Croce, C. M. (2006) MicroRNA signatures in human cancers Nat. Rev. Cancer 6, 857-866
7. Li, C., Feng, Y., Coukos, G., and Zhang, L. (2009) Therapeutic microRNA strategies in human cancer AAPS J. 11, 747-757
8. Deiters, A. (2010) Small molecule modifiers of the microRNA and RNA interference pathway AAPS J. 12, 51-60
9. Schoniger, C. and Arenz, C. (2013) Perspectives in targeting miRNA function Bioorg. Med. Chem. 21, 6115-6118
10. Gumireddy, K., Young, D. D., Xiong, X., Hogenesch, J. B., Huang, Q., and Deiters, A. (2008) Small-molecule inhibitors of microrna miR-21 function Angew. Chem., Int. Ed. 47, 7482-7484
11. Bhat-Nakshatri, P., Wang, G., Collins, N. R., Thomson, M. J., Geistlinger, T. R., Carroll, J. S., Brown, M., Hammond, S., Srour, E. F., Liu, Y., and Nakshatri, H. (2009) Estradiol-regulated microRNAs control estradiol response in breast cancer cells Nucleic Acids Res. 37, 4850-4861
12. Wickramasinghe, N. S., Manavalan, T. T., Dougherty, S. M., Riggs, K. A., Li, Y., and Klinge, C. M. (2009) Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells Nucleic Acids Res. 37, 2584-2595
13. Young, D. D., Connelly, C. M., Grohmann, C., and Deiters, A. (2010) Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma J. Am. Chem. Soc. 132, 7976-7981
14. Shan, G., Li, Y., Zhang, J., Li, W., Szulwach, K. E., Duan, R., Faghihi, M. A., Khalil, A. M., Lu, L., Paroo, Z., Chan, A. W., Shi, Z., Liu, Q., Wahlestedt, C., He, C., and Jin, P. (2008) A small molecule enhances RNA interference and promotes microRNA processing Nat. Biotechnol. 26, 933-940
15. Bose, D., Jayaraj, G., Suryawanshi, H., Agarwala, P., Pore, S. K., Banerjee, R., and Maiti, S. (2012) The tuberculosis drug streptomycin as a potential cancer therapeutic: inhibition of miR-21 function by directly targeting its precursor Angew. Chem., Int. Ed. 51, 1019-1023
16. Maiti, M., Nauwelaerts, K., and Herdewijn, P. (2012) Pre-microRNA binding aminoglycosides and antitumor drugs as inhibitors of Dicer catalyzed microRNA processing Bioorg. Med. Chem. Lett. 22, 1709-1711
17. Zhang, S., Chen, L., Jung, E. J., and Calin, G. A. (2010) Targeting microRNAs with small molecules: from dream to reality Clin. Pharm. Ther. 87, 754-758
18. Cho, W. J., Shin, J. M., Kim, J. S., Lee, M. R., Hong, K. S., Lee, J. H., Koo, K. H., Park, J. W., and Kim, K. S. (2009) miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2 Mol. Cells 28, 521-527
19. Voorhoeve, P. M., le Sage, C., Schrier, M., Gillis, A. J., Stoop, H., Nagel, R., Liu, Y. P., van Duijse, J., Drost, J., Griekspoor, A., Zlotorynski, E., Yabuta, N., De Vita, G., Nojima, H., Looijenga, L. H., and Agami, R. (2006) A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors Cell 124, 1169-1181
20. Lee, K. H., Goan, Y. G., Hsiao, M., Lee, C. H., Jian, S. H., Lin, J. T., Chen, Y. L., and Lu, P. J. (2009) MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer Exp. Cell. Res. 315, 2529-2538
21. Rippe, V., Dittberner, L., Lorenz, V. N., Drieschner, N., Nimzyk, R., Sendt, W., Junker, K., Belge, G., and Bullerdiek, J. (2010) The two stem cell microRNA gene clusters C19MC and miR-371-3 are activated by specific chromosomal rearrangements in a subgroup of thyroid adenomas PloS One 5, e9485
22. Belair, C., Baud, J., Chabas, S., Sharma, C. M., Vogel, J., Staedel, C., and Darfeuille, F. (2011) Helicobacter pylori interferes with an embryonic stem cell micro RNA cluster to block cell cycle progression Silence 2, 7
23. Duca, M., Vekhoff, P., Oussedik, K., Halby, L., and Arimondo, P. B. (2008) The triple helix: 50 years later, the outcome Nucleic Acids Res. 36, 5123-5138
24. Malnuit, V., Duca, M., and Benhida, R. (2011) Targeting DNA base pair mismatch with artificial nucleobases. Advances and perspectives in triple helix strategy Org. Biomol. Chem. 9, 326-336
25. Duca, M., Malnuit, V., Barbault, F., and Benhida, R. (2010) Design of novel RNA ligands that bind stem-bulge HIV-1 TAR RNA Chem. Commun. 46, 6162-6164
26. Thomas, J. R. and Hergenrother, P. J. (2008) Targeting RNA with small molecules Chem. Rev. 108, 1171-1224
27. Guan, L. and Disney, M. D. (2012) Recent advances in developing small molecules targeting RNA ACS Chem. Biol. 7, 73-86
28. Ennifar, E., Paillart, J. C., Bodlenner, A., Walter, P., Weibel, J. M., Aubertin, A. M., Pale, P., Dumas, P., and Marquet, R. (2006) Targeting the dimerization initiation site of HIV-1 RNA with aminoglycosides: from crystal to cell Nucleic Acids Res. 34, 2328-2339
29. Mei, H. Y., Mack, D. P., Galan, A. A., Halim, N. S., Heldsinger, A., Loo, J. A., Moreland, D. W., Sannes-Lowery, K. A., Sharmeen, L., Truong, H. N., and Czarnik, A. W. (1997) Discovery of selective, small-molecule inhibitors of RNA complexes. I. The Tat protein/TAR RNA complexes required for HIV-1 transcription Bioorg. Med. Chem. 5, 1173-1184
30. Zapp, M. L., Stern, S., and Green, M. R. (1993) Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production Cell 74, 969-978
31. Kumar, S., Kellish, P., Robinson, W. E., Jr., Wang, D., Appella, D. H., and Arya, D. P. (2012) Click dimers to target HIV TAR RNA conformation Biochemistry 51, 2331-2347
32. Tor, Y. (2003) Targeting RNA with small molecules ChemBioChem 4, 998-1007
33. Hermann, T. and Westhof, E. (1998) Aminoglycoside binding to the hammerhead ribozyme: a general model for the interaction of cationic antibiotics with RNA J. Mol. Biol. 276, 903-912
34. Leclerc, F. and Cedergren, R. (1998) Modeling RNA-ligand interactions: the Rev-binding element RNA-aminoglycoside complex J. Med. Chem. 41, 175-182
35. Blount, K. F. and Tor, Y. (2006) A tale of two targets: differential RNA selectivity of nucleobase-aminoglycoside conjugates ChemBioChem 7, 1612-1621
36. Guianvarc'h, D., Benhida, R., Fourrey, J. L., Maurisse, R., and Sun, J. S. (2001) Incorporation of a novel nucleobase allows stable oligonucleotide- directed triple helix formation at the target sequence containing a purine.pyrimidine interruption Chem. Commun. 1814-1815
37. Guianvarc'h, D., Fourrey, J. L., Maurisse, R., Sun, J. S., and Benhida, R. (2003) Design of artificial nucleobases for the recognition of the AT inversion by triple-helix forming oligonucleotides: a structure-stability relationship study and neighbour bases effect Bioorg. Med. Chem. 11, 2751-2759
38. Lecubin, F., Benhida, R., Fourrey, J. L., and Sun, J. S. (1999) NMR recognition studies of C·G base pairs by new easily accessible heterobicyclic systems Tetrahedron Lett. 40, 8085-8088
39. Wang, W., Purwanto, M. G., and Weisz, K. (2004) CG base pair recognition by substituted phenylimidazole nucleosides Org. Biomol. Chem. 2, 1194-1198
40. Sasaki, S., Nakashima, S., Nagatsugi, F., Tanaka, Y., Hisatome, M., and Maeda, M. (1995) Design of a novel artificial nucleobase for the selective formation of a triple-complex with a cytosine-guanine base pair Tetrahedron Lett. 36, 9521-9524
41. Griffin, L. C., Kiessling, L. L., Beal, P. A., Gillespie, P., and Dervan, P. B. (1992) Recognition of all four base pairs of double-helical DNA by triple-helix formation: design of nonnatural deoxyribonucleosides for pyrimidine.cntdot.purine base pair binding J. Am. Chem. Soc. 114, 7976-7982
42. Davies, B. P. and Arenz, C. (2006) A homogenous assay for micro RNA maturation Angew. Chem., Int. Ed. 45, 5550-5552
43. Davies, B. P. and Arenz, C. (2008) A fluorescence probe for assaying micro RNA maturation Bioorg. Med. Chem. 16, 49-55
44. Findlay, B., Zhanel, G. G., and Schweizer, F. (2012) Neomycin-phenolic conjugates: polycationic amphiphiles with broad-spectrum antibacterial activity, low hemolytic activity and weak serum protein binding Bioorg. Med. Chem. Lett. 22, 1499-1503
45. Boer, J., Blount, K. F., Luedtke, N. W., Elson-Schwab, L., and Tor, Y. (2005) RNA-selective modification by a platinum(II) complex conjugated to amino- and guanidinoglycosides Angew. Chem., Int. Ed. 44, 927-932
46. Luedtke, N. W., Liu, Q., and Tor, Y. (2003) RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element Biochemistry 42, 11391-11403
47. Thomas, J. R., Liu, X., and Hergenrother, P. J. (2005) Size-specific ligands for RNA hairpin loops J. Am. Chem. Soc. 127, 12434-12435
48. Melo, S. A. and Kalluri, R. (2012) Molecular pathways: microRNAs as cancer therapeutics Clin. Cancer Res. 18, 4234-4239